In lung adenocarcinoma, PTK7 was found to be overexpressed in cancer tissues compared to normal lung tissues, and the positivity of PTK7 expression was higher in cases with ALK mutations and lower in cases with EGFR mutations (37, 79). This evidence concerns the gene PTK7 and lung adenocarcinoma.